Short-term pullbacks or downward corrections in Corcept Therapeutics stock are typically triggered by broader biotechnology sector sell-offs, profit-taking following strong multi-month rallies, or minor investor overreactions to quarterly expense reports and regulatory review timelines. Because high-growth biotech equities are sensitive to market rotations, any temporary macroeconomic uncertainty can introduce volatility.